Articles from Neocis

Yomi® S and YomiPlan® AI Platform Now FDA-Cleared, Offering Unprecedented Precision, Efficiency, and Access for Dentists and Patients

MIAMI, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Neocis®, the leader in robotic-assisted dental surgery, today announced new clinical data highlighting the significant efficiency benefits of its Yomi® Robotic System, the first and only FDA-cleared robotic platform for dental implant procedures.

Dental Economics publishes study by leading Missouri dentist Dr. Jonathan Ehlers on how dental practices are increasing implant volume, efficiency, and profitability by offering robot-guided implant placement.

Dr. Jay Neugarten, an international thought leader in implant dentistry and early adopter of dental robotics, publishes clinical study on the unparalleled accuracy and precision of dental implantation assisted by the Yomi® robotic platform

Despite challenging macroeconomic conditions, Neocis secured $20M in financing in 2023 to accelerate growth, with funding participation from Mirae Asset Financial Group and NVIDIA.

Latest indication allows clinicians to leverage the accuracy, precision, and intraoperative flexibility of robotic assistance when performing alveoloplasty – a key phase of many full-arch cases

New bone reduction feature expands the scope of robot-assisted dental surgery by enabling clinicians to use the Yomi platform for more phases of full-arch rehabilitation

Neocis closed its latest round of funding, led by a prominent dental investor, with participation from Intuitive Ventures and existing partners DFJ Growth, Vivo Capital, Mithril Capital Management, Norwest Venture Partners, and Fred Moll. This additional funding comes as robotic adoption within implant dentistry continues to increase dramatically; to date, the Yomi system has been used to place more than 20,000 implants.